🚀 Last week, our Partner Sophie Baratte, MBA, PhD had the honor to be part of fascinating panel entitled "How to Fund MedTech?" organized by Brabantse Ontwikkelings Maatschappij (BOM), in the Netherlands. 🌟 Alongside distinguished industry professionals, including Janke Dittmer, General Partner at Gilde Healthcare; Eliane Schutte, CEO of Xeltis; Hubert Martens, CEO of Salvia BioElectronics, with Floris Hamel, Investment Manager Life Sciences & MedTech at BOM, as a moderator, we delved into the intricate landscape of funding strategies in the MedTech sector. A big thank you to the organizers for bringing together this panel, and to everyone who attended and engaged in the conversation. If you're interested in learning more about the key takeaways or if you have any questions about MedTech funding, feel free to reach out. #MedTech #FundingStrategies #Innovation #InvestmentBanking
Agile Capital Markets’ Post
More Relevant Posts
-
Overall negative Healthcare & Life Sciences Sentiments recorded in September 2023 The FCF Healthcare & Life Sciences team continuously analyses the current sentiments in the European healthcare & life sciences venture capital funding sector. We observe a negative trend for venture capital funding in all relevant subsectors. The healthcare & life sciences subsectors of Biotech, MedTech and HealthTech are currently all affected negatively. https://lnkd.in/eqSUBxpS #finance #lifesciences #biotechnologie #healthcare #medizintechnik #medtech #healthtech
-
-
Mostly positive Healthcare & Life Sciences Sentiments recorded in August 2023 The FCF Healthcare & Life Sciences team continuously analyses the current sentiments in the European healthcare & life sciences venture capital funding sector. We observe a positive trend for venture capital funding for two out of three subsectors. Both MedTech and HealthTech subsector are currently positively affected, while the BioTech subsector displays a negative trend. https://lnkd.in/eAhdxn_z #finance #lifesciences #biotechnologie #healthcare #medizintechnik #medtech #healthtech
-
-
📉 Mostly Negative Healthcare & Life Sciences Sentiments Recorded in October 2023 The FCF Healthcare & Life Sciences team continuously analyses the current sentiments in the European healthcare & life sciences venture capital funding sector. 🔍 We observe a positive trend for venture capital funding for one out of three subsectors. The MedTech subsector is currently positively affected 🟢, while both BioTech and HealthTech subsectors display a negative trend 🔴. Learn more in the first comment below. #Healthcare #LifeSciences #VentureCapital #MedTech #BioTech #HealthTech #EuropeanMarket #FCFInsights #MarketTrends
-
-
Overall positive Healthcare & Life Sciences Sentiments recorded in July 2023 The FCF Healthcare & Life Sciences team continuously analyses the current sentiments in the European healthcare & life sciences venture capital funding sector. For first time in 2023, we observe a positive trend for venture capital funding in all relevant subsectors. The healthcare & life sciences subsectors of Biotech, MedTech and HealthTech are currently all affected positively. https://lnkd.in/epf6QShA #finance #lifesciences #biotechnologie #healthcare #medizintechnik #medtech
-
-
We're proud to be a #mediapartner of the LSX World Congress — Connecting #Innovation with #Capital. The #event takes place from 29–30 April in London, with 2000+ attendees joining. The 10th LSX World Congress gathers the founders and CEOs of innovative #biotech, #medtech and #healthtech #startups through to healthcare giants, and everyone in between. They attend alongside the sector’s most active #investors, #pharma, medtech and healthtech BD&L teams and R&D leaders. #LSXWorld brings together the people who are developing technologies, solutions and new business models to tackle the biggest healthcare challenges in the industry today, and helps answer the question; what’s next and how do we get there? Find out more 👉 https://lnkd.in/ddbtpquX LSX - partnering for Life Science eXecutives #messengersinscience
-
-
At HiRO, we understand the hurdles biotech companies face from conception to market. Our tailored CRO services support these pioneers in transforming healthcare through innovation. Dive into how we're reshaping the journey for biotech innovations and providing the tools needed for success. Learn how HiRO is driving biotech breakthroughs: https://lnkd.in/gkhsnk-3 #BiotechInnovation #ClinicalResearch #HiRO
-
-
Product Design and Strategy | HTN Judge 2023 | BIMA100 Judge 2023 | Design Leadership | Making a positive impact in healthcare with design and research
How can design increase people's ability to take action within digital health? 🎉 This is the talk opportunity I've been waiting for a while. Many digital health products invest primarily in medical and tech, which is fair but leaves user experience to chance and guesses. User experience is highly linked to engagement and how a product can transform your life, which, in health, is equal to adherence, increased efficacy and quality of life. If your users can't take action, your product will fail, no matter what. I will be talking about what drives us to try new solutions and give some practical usability examples to put all chances on your side when people decide to engage with your digital solution. 👋 See you in Boston at the LSX - partnering for Life Science eXecutives conference :) #productdesign #usability #lsxWorldCongress #digitalhealth #biotech #medtech #healthtech #digitalhealth https://lnkd.in/esVMbdB
This time next week we'll be in Boston for the LSX USA Congress — a gathering of senior leaders from across the world of biotech, medtech and healthtech. Thomas Michalak, Graphite's Creative Director, will be delivering a talk on Day 1 about 'Designing for Impact and Creating Digital Health Products That Drive Engagement'. Will you be there? Don't miss it! 💡 #LSXUSA #biotech #medtech #healthtech #digitalhealth LSX - partnering for Life Science eXecutives https://lnkd.in/esVMbdB
-
📌 Exploring the Future of Healthcare: 2023 & Beyond As we move closer to 2024, the healthcare market is changing fast. Patent expirations of big biological products and the challenges and changes in #biotech, #medtech, and #healthtech spaces. Join our expert panel as they discuss: 🔸 Current trends in deal-making and investments. 🔸 How investors see biotechs with soon-to-expire patents. 🔸 Predictions on future investments, deal sizes, and what's next for the IPO market across sectors. Our Panel include: Regina Hodits, Wellington Partners Life Sciences Geraldine O'Keeffe, EQT Life Sciences Diana Saraceni, Panakes Partners Gil Bar-Nahum, PhD, Jefferies Michael Rice, LifeSci Advisors, LLC Learn more about the challenges and chances in healthcare at Investival. 👉 See the agenda:https://lnkd.in/dzJe3W4k #Investival #HealthcareFuture #PanelDiscussion
-
-
📉 Mostly positive Healthcare & Life Sciences Sentiments recorded in November 2023 The FCF Healthcare & Life Sciences team continuously analyses the current sentiments in the European healthcare & life sciences venture capital funding sector. 🔍 We observe a positive trend for venture capital funding for two out of three subsectors. Both BioTech and MedTech subsector are currently positively affected 🟢, while the HealthTech subsector displays a negative trend🔴. Learn more in the first comment below. #Healthcare #LifeSciences #VentureCapital #MedTech #BioTech #HealthTech #EuropeanMarket #FCFInsights #MarketTrends
-
-
We are thrilled to announce that we will be attending and sponsoring the Ontario Bioscience Innovation Organization (OBIO) Innovation Summit this February. The summit brings together thought leaders, investors, and entrepreneurs to discuss and showcase innovations in the MedTech and Bioscience industries. We are proud to be part of this event and excited to see what the future holds. #OBIO #OBIOInvestmentSummit #OBIOInvestmentSummit2024 #OIS #OIS2024 #healthcare #healthtech #healthtechnology #lifesciences #investment #medtech #businessdevelopment #therapeutics #innovativesolutions #innovationsinhealthcare #medicaldevices #diagnostics #digitalhealth
-
Investment Manager Life Sciences & Medtech at Brabantse Ontwikkelings Maatschappij (BOM)
9moIt was great having Sophie Baratte, MBA, PhD in the panel! Truly enjoyed the discussion between Sophie, Janke Dittmer and Eliane Schutte. The audience obtained a tonne of valuable information relating to Medtech Funding!